Epstein-Barr Virus-Positive Hemophagocytic Lymphohistiocytosis Following COVID-19 Vaccination in a Pediatric Patient.

Abstract

Pediatric Blood & CancerEarly View e30189 LETTER TO THE EDITOR Epstein–Barr Virus-Positive Hemophagocytic Lymphohistiocytosis Following COVID-19 Vaccination in a Pediatric Patient Amanda Arand, Corresponding Author Amanda Arand aarand@iu.edu orcid.org/0000-0001-5480-7326 Indiana University School of Medicine, Indianapolis, Indiana, USA Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA Correspondence Amanda Arand, Indiana University School of Medicine, Indianapolis, IN, USA. Email: aarand@iu.eduSearch for more papers by this authorKathleen Overholt, Kathleen Overholt Indiana University School of Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USASearch for more papers by this authorSeethal A. Jacob, Seethal A. Jacob Indiana University School of Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, Indiana, USASearch for more papers by this authorJennifer A. Belsky, Jennifer A. Belsky orcid.org/0000-0002-2260-0395 Indiana University School of Medicine, Indianapolis, Indiana, USA Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USASearch for more papers by this author Amanda Arand, Corresponding Author Amanda Arand aarand@iu.edu orcid.org/0000-0001-5480-7326 Indiana University School of Medicine, Indianapolis, Indiana, USA Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA Correspondence Amanda Arand, Indiana University School of Medicine, Indianapolis, IN, USA. Email: aarand@iu.eduSearch for more papers by this authorKathleen Overholt, Kathleen Overholt Indiana University School of Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USASearch for more papers by this authorSeethal A. Jacob, Seethal A. Jacob Indiana University School of Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, Indiana, USASearch for more papers by this authorJennifer A. Belsky, Jennifer A. Belsky orcid.org/0000-0002-2260-0395 Indiana University School of Medicine, Indianapolis, Indiana, USA Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USASearch for more papers by this author First published: 11 January 2023 https://doi.org/10.1002/pbc.30189Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issuee30189 RelatedInformation